Filter by
NewsThe first psychobiotic in BrazilApsen, located in São Paulo, Brazil, in partnership with Lallemand Health Solutions, are launching in September the first probiotic formulation for the brain-gut axis on the Brazilian market, with approved health claims by the Brazilian Health Authorities, ANVISA. Probid and […]
Oct 13, 2020
NewsAll together “Running for research” to fund Prader-Willis syndrome researchLallemand Health Solutions is pleased to announce its partnership with Prader-Willi syndrome association (PWS) | USA, and “Running for Research,” a charitable initiative to raise funds for PWS research at the University of Florida. The next run will take place at the Walt Disney World Marathon from […]
Sep 9, 2020
NewsMeet ROSELLA: A convenient orally administered probiotic shown to support women’s intimate healthLallemand Health Solutions will officially launch ROSELLA, its new highly documented licensed strain for Women’s intimate health at Vitafoods Europe Virtual Expo on September 7 2020. L. plantarum P17630 (Proge P17630®), ROSELLA, licensed from PROGE FARM®, Italy, is a unique […]
Sep 1, 2020
NewsLallemand Health Solutions close a major licensing deal with Proge Farm®Lallemand Health Solutions and Proge Farm® are proud to announce that they have just closed a major licensing deal for the commercialization by Lallemand Health Solutions of Proge Farm®’s established probiotic strain L. plantarum P17630 (Proge P17630®), which has specific […]
Jul 17, 2020
NewsLallemand innovative probiotic yeast solutionsAs an expert in yeast fermentation and production since 1923, Lallemand presents a wide range of innovative probiotic yeast solutions. Rediscover S. boulardii, a time tested yeast mastered and perfected from lab to shelf through a new website and instructive […]
Jul 8, 2020
NewsIntroducing CEREBIOME®: Pioneering psychobiotic. Game-changing science.Lallemand Health Solutions launches the brand CEREBIOME® (previously known as Probio’Stick®), a new name for an existing formula combining: Lactobacillus helveticus Rosell®-52 and Bifidobacterium longum Rosell®-175. As pioneer and expert in research on the brain-gut axis, Lallemand Health Solutions launches […]
Jun 17, 2020
NewsChina health authorities’ acknowledge L. helveticus Rosell®-52, B. infantis Rosell®-33 and B. bifidum Rosell®-71 for safe use in infant formulaLallemand Health Solutions’ three probiotic strains L. helveticus Rosell®-52 (R0052), B. infantis Rosell®-33 (R0033) and B. bifidum Rosell®-71 (R0071), have now completed the approval process by the National Health Commission of the People’s Republic of China for use in infant […]
Jun 8, 2020
NewsThe Lallemand group on track for finding a COVID-19 vaccineThe Lallemand group, in partnership with Biotechnologies Ulysse and Bio-K Plus, all Canadian companies, are joining forces to develop a vaccine against the COVID-19 pandemic. In a news report by journalist Frédéric Arnould broadcasted on Canadian national television last week, […]
May 11, 2020
NewsLallemand group is donating 3,200 personal protective masksThe Lallemand group is donating 3,200 surgical and N95 masks to local health authorities in the Montreal (Canada) and Cantal (France) regions, where its plants for the production of probiotics and specialty food cultures are located. “To get through the […]
Mar 30, 2020
NewsCOVID-19: Lallemand Health Solutions has a continuity plan in placeWith the rapidly evolving COVID-19 pandemic, Lallemand Health Solutions (LHS) further deployed additional measures to its initial contingency plan, to ensure employees and operations safety, as well as business continuity. “In these times of adversity, it is our duty to […]
Mar 17, 2020